Yin et al. found that increased plasma CXCL9, CXCL10, and CXCL11 measured during primary HIV-1 infection predicted long-term HIV disease prognosis in men who have sex with men (MSM) and has the potential as a novel biomarker for clinical use (60). This evidence concerns the gene CXCL9 and HIV-1 infection.